Home/ImageneBio/Dr. Ben Porter-Brown

DB

Dr. Ben Porter-Brown

Chief Medical Officer

Therapeutic Areas

Immunological Diseases Autoimmune Diseases Inflammatory Diseases Alopecia Areata

ImageneBio Pipeline

Drug	Indication	Phase
IMG-007	Immunological, Autoimmune and Inflammatory Diseases (e.g., Alopecia Areata)	Phase 2

Leadership Team at ImageneBio

Kristin Yarema, Ph.D.

Chief Executive Officer and Director

Kurinji Pandiyan, Ph.D.

Chief Strategy and Operations Officer

Renuka Sivendran, Ph.D.

Chief Technical Officer

View full ImageneBio profile